Shocking nerve pain away: new device trial for diabetic neuropathy

NCT ID NCT05777317

Ongoing Symptom relief Sponsor: Nevro Corp Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests whether a device that sends mild electrical pulses to the spinal cord (10 kHz SCS) can reduce pain and improve nerve function in people with painful diabetic neuropathy. About 143 participants will either get standard medical care alone or the device plus standard care. The goal is to see if more people get at least 50% pain relief and show measurable nerve improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 10 kHz spinal cord stimulation (SCS) device
What this could lead to: If successful, this could offer a new option to significantly reduce chronic pain and improve nerve function in people with painful diabetic neuropathy.
What could go wrong: This is a mid-stage trial with 143 participants, so results may not apply to everyone. The device requires surgery and carries risks like infection or device malfunction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAINFUL DIABETIC NEUROPATHY

Contacts and locations

Locations

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States
Touchstone Interventional Pain Center

Medford, Oregon, 97504, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.